Original Research

JCP
Public Health Nurse-Delivered Group CBT for PPD
Original Research

July 24, 2023

The increase in postpartum depression during the pandemic highlights a need for accessible interventions. In this study, online group CBT significantly reduced depression, worry, and rejection and pathological anger...
, , , et al
PCC
External Ear and Minor Physical Anomalies in Patients With Depression
Original Research

July 20, 2023

External ear anomalies are more prevalent in patients with depressive disorder, supporting the neurodevelopmental theory of depression.
, , , et al
PCC
Quality of Life of Caregivers of Patients With Mental Illness
Original Research

July 18, 2023

The care of a person with mental illness involves multiple challenges, leading to negative impacts on the caregivers’ mental health.
, , , et al
JCP
Inflammatory Features in Prodromal Psychosis
Original Research

July 17, 2023

This study suggests that niacin response tests should be considered in early psychosis identification and prediction.
, , , et al
PCC
Managing ADHD During the COVID-19 Pandemic
Original Research

July 13, 2023

Adults with ADHD reported increased difficulty in managing their symptoms during the COVID-19 pandemic.
, , , et al
JCP
Tonic Immobility and Peritraumatic Dissociation in PTSD
Original Research

July 12, 2023

Tonic immobility and peritraumatic dissociation in reaction to trauma are associated with later psychopathology. This study suggests that interventions targeting these reactions could reduce future PTSD risk.
,
JCP
SNRIs and Hypertensive Disorders of Pregnancy
Original Research

July 10, 2023

Hypertensive disorders of pregnancy (HDP) are a major complication. In this study, the risk of HDP with SNRIs (9.5%) was significantly higher than with SSRIs (5.5%).
, , , et al
JCP
Cardiovascular Risk by SMI Subtype
Original Research

July 5, 2023

Cardiovascular disease is the leading cause of death for people with serious mental illness. A clinical decision support tool produced a significant relative reduction in total modifiable cardiovascular risk...
, , , et al
PCC
Functional Disability in US Military Veterans
Original Research

July 4, 2023

Improved identification and integrated clinical management of sociodemographic, military, and health risk factors may help mitigate disability risk and promote the maintenance of functional capacity in US veterans.
, , , et al
JCP
Subcallosal Cingulate Gyrus Deep Brain Stimulation for TRD
Original Research

June 28, 2023

DBS targeting the subcallosal cingulate gyrus to treat depressive symptoms resulted in response and remission rates of 75% and 62.5%.
, , , et al
PCC
Initiative to Improve Antipsychotic Metabolic Monitoring
Original Research

June 27, 2023

Interprofessional monthly care conferences can improve coordination of care across mental health and primary care settings.
, , , et al
JCP
Vitamin D3 and Omega-3 Fatty Acids for Depression Prevention
Original Research

June 26, 2023

Although several lines of evidence suggest that vitamin D3 and omega-3 fatty acids promote mood health, neither supplement showed benefits for indicated and selective prevention of late-life depression.
, , , et al
PCC
Suicidal Behavior in First-Episode Schizophrenia
Original Research

June 20, 2023

Suicidal behavior is most prevalent in the early phases of illness in first-episode schizophrenia, particularly during hospital admission.
, ,
JCP
Using Natural Language Processing in Suicide Risk Prediction
Original Research

June 19, 2023

Natural language processing, a subfield of AI that evaluates textual patterns, added predictive accuracy to the current model of using structured EHR data in suicide risk prediction.
, , , et al
JCP
Mild Vitamin C Deficiency Is Common in Psychiatric Inpatients
Original Research

June 14, 2023

Almost two-thirds of inpatients met criteria for mild vitamin C deficiency, and folate and vitamin D levels strongly predicted vitamin C levels.
, ,
JCP
Weight Loss and Lifestyle Intervention for Obstructive Sleep Apnea
Original Research

June 12, 2023

A weight loss and lifestyle intervention improved OSA-related impaired daily functioning and psychiatric symptoms.
, , , et al
JCP
Lurasidone and Anxiety Symptoms in Bipolar Depression
Original Research

June 7, 2023

Lurasidone was superior to placebo at reducing anxiety in bipolar depression. Change in anxiety symptoms was predicted by sleep disturbance at baseline.
, , , et al
PCC
Early Maladaptive Schema Domains and the Menses
Original Research

May 30, 2023

Early maladaptive schemas are among the most important factors that can influence women’s psychological well-being, especially when overlapping with the biological, mental, and social variations of menstruation.
, , , et al
JCP
Social Support and Symptoms of PTSD
Original Research

May 29, 2023

Social support affects the development and persistence of PTSD. A sense of belongingness to family and/or friends was associated with fewer PTSD symptoms in older adults.
, , , et al
JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
, , , et al
JCP
Suicidal Ideation in Residential Substance Use Treatment
Original Research

May 22, 2023

People with substance use disorders (SUDs) and chronic health/psychiatric conditions may have higher risk for suicidal ideation than those with only SUD. Integrated treatments for patients with suicidal ideation...
, , , et al
JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and...
, , , et al
PCC
Screening and Referral Algorithm for Substance Use
Original Research

May 18, 2023

The New Hampshire Hospital Screening and Referral Algorithm, a new data driven substance use screening instrument, holds promise in improving identification of substance use in a seriously mentally ill...
, , , et al
JCP
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management
Original Research

May 17, 2023

Among 430 youth beginning treatment for depression, about one-quarter achieved remission within 6 months. The odds of remitting decreased as baseline symptom severity increased.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe